Biogen Inc.
Location
Massachusetts
Founded
1978-02-28
Website
Risk Signals
2646 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Biological Products, Except Diagnostic Substances, Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Biogen Inc.
Live alerts from global media, monitored by Business Radar
2025-04-16 (theretirementgroup.com)
Biogen Trust as Beneficiary of Traditional IRA or Retirement Plan
Explore how Biogen employees can leverage trusts as beneficiaries for their IRA or Biogen-sponsored retirement plans to secure post-death distributions and tax benefits. Understand the specific requirements and advantages for Biogen workers to make informed estate planning decisions.
Read more
2025-03-20 (marketbeat.com)
Harvest Fund Management Co. Ltd Grows Stock Holdings in Biogen Inc. (NASDAQ:BIIB)
Harvest Fund Management Co. Ltd grew its stake in Biogen Inc. (NASDAQ:BIIB - Free Report) by 27.8% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 8,576 shares of the biotechnology company's stock after purc
Read more
2025-03-17 (tradingview.com)
SANGAMO THERAPEUTICS, INC SEC 10-K Report — News
Sangamo Therapeutics, Inc., a genomic medicine company focused on developing transformative therapies for serious neurological diseases, has released its annual Form 10-K report. The report provides a comprehensive overview of the company's financial performance, business operations, strategic init…
Read more
2025-03-08 (owler.com)
Reports - Press Release: Biogen : QALSODY (tofersen injection) Receives Conditional Marketing Authorization from Health Canada as the First ALS Treatment Targeting a Genetic Cause
/CNW/ - Biogen Canada Inc. announced today that Health Canada has issued marketing authorization with conditions (Notice of Compliance with Conditions (NOC/c))...
Read more
2025-03-07 (wsj.com)
Biogen Stock Falls After Company Gives Weaker-Than-Expected Financial Outlook
Biogen Stock Falls After Company Gives Weaker-Than-Expected Financial Outlook ... Biogen shares fell, after the biotechnology company forecast lower-than-expected...
Read more
2025-03-03 (investors.com)
S&P 500: Own 15 Stocks Morningstar Calls 'Wealth Destroyers?' | Investor's Business Daily
The S&P 500 can generate massive wealth. But stocks can decimate portfolio, too. Morningstar blames 15 stocks for billions in losses.
Read more
2025-02-27 (stocktitan.net)
Denali Reports 2024 Results: Tividenofusp Alfa Advances With Breakthrough Therapy Status | DNLI Stock News
Denali posted $422.8M annual loss with $1.19B cash position while advancing tividenofusp alfa for Hunter syndrome toward BLA submission with FDA Breakthrough status.
Read more
2025-02-27 (fool.com)
AbCellera Biologics (ABCL) Q4 2024 Earnings Call Transcript |
ABCL earnings call for the period ending December 31, 2024.
Read more
2025-02-15 (reporter.am)
William Blair Has Optimistic Outlook of Biogen Q1 Earnings -
Read William Blair Has Optimistic Outlook of Biogen Q1 Earnings at The AM Reporter
Read more